News

May 12 – International Nursing Day

The date of the election to celebrate this anniversary coincides with the birth of nurse Florence Nightingale, a pioneer of modern nursing

Leer más about May 12 – International Nursing Day

Researchers identify a possible therapy against Rendu-Osler disease

Research It is a rare disease that causes malformations in blood vessels. The study has discovered the implication of a protein in the development of the pathology.

Leer más about Researchers identify a possible therapy against Rendu-Osler disease

Isabel Fabregat receives a grant from the Ramón Areces Foundation to study liver fibrosis

The Ramón Areces Foundation has awarded Grants for Research in Life Sciences and Matter corresponding to its 20th edition. In ​​intercellular dialogue and interactome area, Dr. Isabel Fabregat, head of the research group “TGF-beta and cancer” at IDIBELL, in collaboration with Drs. Aránzazu Sánchez and Blanca Herrera from the Complutense University of Madrid, have received one of the grants.

Leer más about Isabel Fabregat receives a grant from the Ramón Areces Foundation to study liver fibrosis

60% of Covid-19 patients develop neurological symptoms

60% of Covid-19 inpatients develop neurological symptoms and 12% of post-Covid patients have neurological sequelae.

Leer más about 60% of Covid-19 patients develop neurological symptoms

Saturday was the day to enjoy and experiment in the Hospitalet science park

This year within the framework of the Hospitalet Spring Festival, we enjoyed again in the Science Park.

Leer más about Saturday was the day to enjoy and experiment in the Hospitalet science park

We launch VacunAcció: a project to immunize against fake news

IDIBELL and the Virolai school, together in a new educational initiative of the Escolab program of the Barcelona City Council

Leer más about We launch VacunAcció: a project to immunize against fake news

IDIBELL and Bellvitge Hospital lead a study on the effectiveness of icatibant against COVID-19

Bellvitge Biomedical Research Institute (IDIBELL) and Bellvitge University Hospital had launched a clinical study, along with the pharmaceutical company Takeda, to evaluate the efficacy and safety of Icatibant as a treatment against COVID-19.

Leer más about IDIBELL and Bellvitge Hospital lead a study on the effectiveness of icatibant against COVID-19

Identified the genetic mechanisms for the acquisition of resistance to antibiotics in H. parainfluenzae

The work of the Epidemiology of Bacterial Infections research group of IDIBELL and HUB indicates that the bacteria could achieve the resistance through the acquisition of mobile DNA fragments.

Leer más about Identified the genetic mechanisms for the acquisition of resistance to antibiotics in H. parainfluenzae

IDIBELL celebrates the Kickoff Meeting on Health Research Projects awarded by ISCIII

Last Tuesday, April 20th, within the Areté Training Program, the IDIBELL AES-2020 Kick Off Meeting was held, aimed at all researchers who have obtained a health research project within the “2020 AES Call” funded by the ISCIII.

Leer más about IDIBELL celebrates the Kickoff Meeting on Health Research Projects awarded by ISCIII
Scroll to Top